Global Glioblastoma Multiforme (GBM) Therapeutics Market Size, Status and Forecast 2019-2025

2019-01-10 / 3900.00 / Pharma & Healthcare / 97 Pages

Description

Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pipeline.
North America dominated the global market in 2017, accounting for over 35% share in terms of revenue. Europe was another major market for glioblastoma multiforme (GBM) therapeutics in 2017. Technological advancement is a major driver of the market in North America and Europe.
In 2018, the global Glioblastoma Multiforme (GBM) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Glioblastoma Multiforme (GBM) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glioblastoma Multiforme (GBM) Therapeutics development in United States, Europe and China.

The key players covered in this study
Merck
Roche
Arbor Pharmaceuticals
Pfizer
AbbVie
Amgen
Bristol-Myers Squibb
Sun Pharmaceuticals
Teva Pharmaceutical
Emcure Pharmaceuticals

Market segment by Type, the product can be split into
Chemotherapy
Targeted Drug Therapy
Radiation Therapy

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Glioblastoma Multiforme (GBM) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Glioblastoma Multiforme (GBM) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Glioblastoma Multiforme (GBM) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Targeted Drug Therapy
1.4.4 Radiation Therapy
1.5 Market by Application
1.5.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size
2.2 Glioblastoma Multiforme (GBM) Therapeutics Growth Trends by Regions
2.2.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions (2014-2025)
2.2.2 Glioblastoma Multiforme (GBM) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Manufacturers
3.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Manufacturers (2014-2018)
3.1.2 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Glioblastoma Multiforme (GBM) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players Head office and Area Served
3.3 Key Players Glioblastoma Multiforme (GBM) Therapeutics Product/Solution/Service
3.4 Date of Enter into Glioblastoma Multiforme (GBM) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-2019)
4.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Glioblastoma Multiforme (GBM) Therapeutics Market Size (2014-2019)
5.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in United States
5.3 United States Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
5.4 United States Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application

6 Europe
6.1 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size (2014-2019)
6.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in Europe
6.3 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
6.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application

7 China
7.1 China Glioblastoma Multiforme (GBM) Therapeutics Market Size (2014-2019)
7.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in China
7.3 China Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
7.4 China Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application

8 Japan
8.1 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size (2014-2019)
8.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in Japan
8.3 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
8.4 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size (2014-2019)
9.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
9.4 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application

10 India
10.1 India Glioblastoma Multiforme (GBM) Therapeutics Market Size (2014-2019)
10.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in India
10.3 India Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
10.4 India Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size (2014-2019)
11.2 Glioblastoma Multiforme (GBM) Therapeutics Key Players in Central & South America
11.3 Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
11.4 Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.1.4 Merck Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.2.4 Roche Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Arbor Pharmaceuticals
12.3.1 Arbor Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.3.4 Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.3.5 Arbor Pharmaceuticals Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.4.4 Pfizer Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 AbbVie
12.5.1 AbbVie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.5.4 AbbVie Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.5.5 AbbVie Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.6.4 Amgen Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.7.4 Bristol-Myers Squibb Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Sun Pharmaceuticals
12.8.1 Sun Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.8.4 Sun Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.8.5 Sun Pharmaceuticals Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.9.4 Teva Pharmaceutical Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.9.5 Teva Pharmaceutical Recent Development
12.10 Emcure Pharmaceuticals
12.10.1 Emcure Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Glioblastoma Multiforme (GBM) Therapeutics Introduction
12.10.4 Emcure Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
12.10.5 Emcure Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


Table of Figures

List of Tables and Figures

Table Glioblastoma Multiforme (GBM) Therapeutics Key Market Segments
Table Key Players Glioblastoma Multiforme (GBM) Therapeutics Covered
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Targeted Drug Therapy Figures
Table Key Players of Targeted Drug Therapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Glioblastoma Multiforme (GBM) Therapeutics Report Years Considered
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Regions 2014-2019
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Regions 2014-2019
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Share by Manufacturers in 2018
Table Global Glioblastoma Multiforme (GBM) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Glioblastoma Multiforme (GBM) Therapeutics Product/Solution/Service
Table Date of Enter into Glioblastoma Multiforme (GBM) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Share by Type (2014-2019)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Share by Application (2014-2019)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Application in 2018
Figure United States Glioblastoma Multiforme (GBM) Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2018-2019)
Table United States Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2014-2019)
Table United States Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2014-2019)
Figure Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2018-2019)
Table Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2014-2019)
Table Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2014-2019)
Figure China Glioblastoma Multiforme (GBM) Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2018-2019)
Table China Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2014-2019)
Table China Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2014-2019)
Figure Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2018-2019)
Table Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2014-2019)
Table Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2018-2019)
Table Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2014-2019)
Figure India Glioblastoma Multiforme (GBM) Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2018-2019)
Table India Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2014-2019)
Table India Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Glioblastoma Multiforme (GBM) Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Glioblastoma Multiforme (GBM) Therapeutics Market Share (2018-2019)
Table Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Share by Type (2014-2019)
Table Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Roche Company Details
Table Roche Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Arbor Pharmaceuticals Company Details
Table Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure Arbor Pharmaceuticals Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Arbor Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure Sun Pharmaceuticals Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Sun Pharmaceuticals Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Emcure Pharmaceuticals Company Details
Table Emcure Pharmaceuticals Revenue in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)(Million US$)
Figure Emcure Pharmaceuticals Revenue Growth Rate in Glioblastoma Multiforme (GBM) Therapeutics Business (2014-2019)
Table Emcure Pharmaceuticals Recent Development
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Share by Regions in 2025
Figure United States Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Product (2019-2025)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Product in 2025
Table Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2025)
Figure Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory